(Q78445240)
Statements
Standard-dose anti-CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study (English)
M Itälä
C H Geisler
E Kimby
E Juvonen
G Tjonnfjord
K Karlsson
1 September 2002
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference